[Federal Register Volume 77, Number 183 (Thursday, September 20, 2012)]
[Notices]
[Pages 58433-58435]
[FR Doc No: 2012-23237]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-67863; File No. SR-NYSEARCA-2012-94]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
of Proposed Rule Change Proposes [sic] To Amend Commentary .06 to NYSE
Arca Options Rule 6.4 To Permit the Exchange To List Additional Strike
Prices Until the Close of Trading on the Second Business Day Prior to
Monthly Expiration.

September 14, 2012.
    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of
1934 (the ``Act'') \2\ and Rule 19b-4 thereunder,\3\ notice is hereby
given that, on September 6, 2012, NYSE Arca, Inc. (the ``Exchange'' or
``NYSE Arca'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I, II,
and III below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C.78s(b)(1).
    \2\ 15 U.S.C. 78a.
    \3\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to proposes to [sic] amend Commentary .06 to
NYSE Arca Options Rule 6.4 to permit the Exchange to list additional
strike prices until the close of trading on the second business day
prior to monthly expiration. The text of the proposed rule change is
available on the Exchange's Web site at www.nyse.com, at the principal
office of the Exchange, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The purpose of this filing is to amend Commentary .06 to NYSE Arca
Options Rule 6.4 to permit the Exchange to add additional strikes until
the close of trading on the second business day prior to a monthly
expiration.
    NYSE Arca Options Rule 6.4 currently permits the Exchange to open
additional series of individual stock options until the first calendar
day of the month in which the option expires or until the fifth
business day prior to expiration if unusual market conditions exist.\4\
Options market participants generally prefer to focus their trading in
strike prices that immediately surround the price of the underlying
security. However, if the price of the underlying stock moves
significantly, there may be a market need for additional strike prices
to adequately account for market participants risk management needs in
a stock. In these situations, the Exchange

has the ability to add additional series at strike prices that are
better tailored to the risk management needs of market participants.\5\
The Exchange may make the determination to open additional series for
trading when the Exchange deems it necessary to maintain an orderly
market, to meet customer demand, or when certain price movements take
place in the underlying market.\6\ If the market need occurs prior to
five business days prior to expiration, then the market participants
may have access to an option contract that is more tailored to the
movement in the underlying stock.\7\ However, if the market need to
manage risk due to unusual market conditions comes to light anytime
from five to two days prior to expiration, then market participants are
left without a contract that is tailored to manage their risk.\8\ For
example:
---------------------------------------------------------------------------

    \4\ See Commentary .06 to NYSE Arca Options Rule 6.4. `Until the
fifth business day prior' generally means up through the end of the
day on the Friday of the week prior to expiration week. When options
were first approved for listing and trading in the United States,
the generally uniform rules of the options exchanges restricted the
addition of new series ``until the first calendar day of the month
in which the option expires.'' At various times in 1985, exchanges
were granted authority to list new equity options series until five
business days prior to expiration under unusual market conditions.
In 1985 there were two main concerns expressed by the Commission:
(i) Worry over the proliferation of strikes and possible capacity
concerns, and (ii) effective and timely communication to market
participants about the new strikes. At the time, though, exchanges
were only allowed to list three expiration months per issue, and
were expanding from listing three strikes to listing five strikes.
Since then, there has been a continual expansion of the number of
strikes, the number of expiration months, and alternative expiration
days. Following the restructuring of OPRA in 2003, each exchange
became responsible for purchasing sufficient capacity to handle its
own quotes generated by the series and classes it listed. Also, when
options were first listed, additional strikes were communicated via
teletype and firm wires to branch offices, firm back offices, and
OCC. As communications were improved, through the use of fax
machines and then email, the time to send notifications decreased
significantly. Now, with the adoption of Streamline Options Series
Adds (``SOSA'') by OCC, notification of new strikes is in real time
throughout the industry.
    \5\ See NYSE Arca Options Rule 6.4.
    \6\ See NYSE Arca Options Rule 6.4(a).
    \7\ See NYSE Arca Options Rule 6.4(a).
    \8\ While these situations are relatively rare, the Exchange
represents that approximately two times a month there is a
legitimate need to add additional strikes closer to expiration than
the five business day limitation permits, due to it being necessary
to maintain an orderly market, to meet customer demand, or when
certain price movements take place in the underlying market.
---------------------------------------------------------------------------

     On October 17, 2011, a Monday of the week that monthly
options expired, Crocs Inc. (CROX) closed at $26.65.
     After the close of trading the issuer published a warning
regarding earnings, and on Tuesday morning the underlying opened at
$17.40.
     The lowest expiring series were the $18 strike calls and
puts. The Exchange was unable to add additional series to tailor the
risk management needs of market participants in the stock due in a
situation where the stock moves more than 35%.
    In this situation, investors had no nearest term strikes to
effectively manage their risk in the underlying stock, CROX. Because of
the current five-days-before-expiration restriction, investors were
unable to tailor their hedging activities in options and effectively
manage their risk going into expiration.\9\
---------------------------------------------------------------------------

    \9\ The Exchange notes that if the proposed rule were in place,
the Exchange would have added $15, $16, and $17 strikes expiring the
following Saturday.
---------------------------------------------------------------------------

    The Exchange proposes to permit the listing of additional strikes
until the close of trading on the second business day prior to
expiration in unusual market conditions. Since expiration of the
monthly contract is on a Saturday, the close of trading on the second
business day will typically fall on a Thursday. However, in the cases
where Friday is a holiday during which the Exchange is closed, the
close of trading on the second business day will occur on a Wednesday.
The Exchange will continue to make the determination to open additional
series for trading when the Exchange deems it necessary to maintain an
orderly market, to meet customer demand, or when certain price
movements take place in the underlying market. The proposed change will
provide an additional four days to the Exchange to gauge market impact
of the underlying stock and to react to any market conditions that
would render additional series prior to expiration beneficial to market
participants. The Exchange believes that the impact on the market from
the proposed change will be very minimal to market participants,
however it will be extremely beneficial in that minority of situations
where unusual market conditions dictate immediately prior to
expiration. The proposal would simply allow participants to adjust
their risk exposure in narrow situations when an unusual market event
occurred on trading days 2, 3, 4, 5 prior to expiration.
    This proposal does not raise any capacity concerns on the Exchange,
because the changes have no material difference in impact from the
current rules. The Exchange notes the proposed change allows for new
strikes that would otherwise be permitted to add under existing rules
either on the fifth day prior or immediately after expiration.\10\ A
strike which opens two days prior to expiration will have minimal
impact on quoting, as it adds two series out of hundreds of thousands,
and only for a small number of days.\11\ Thus, any additional strikes
that may be added under the proposed change would have no measurable
effect on systems capacity.
---------------------------------------------------------------------------

    \10\ Any new strikes added under this proposal would be added in
a manner consistent with the range limitations described in NYSE
Arca Options Rule 6.4A.
    \11\ In the case of a multi-stock event where multiple stocks
may be subject to unusual market conditions, a strike which opens
two days prior to expiration will also have minimal impact on
quoting, as it adds two series per stock out of hundreds of
thousands, and only for a small number of days.
---------------------------------------------------------------------------

    The Exchange discussed the proposed listing and trading of series
during expiration week with the OCC. The OCC represented that it is
able to accommodate the proposal and would have no operational concerns
with adding new series on any day except the last day of trading an
expiring series.
2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) of the Securities Exchange Act of 1934 (the
``Act''),\12\ in general, and furthers the objectives of Section
6(b)(5) of the Act,\13\ in particular, in that it is designed to
promote just and equitable principles of trade, remove impediments to
and perfect the mechanisms of a free and open market and a national
market system and, in general, to protect investors and the public
interest.
---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78f(b).
    \13\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    The Exchange believes that providing an additional four days to the
Exchange to gauge market impact and to react to any market conditions
prior to expiration beneficial [sic] will result in a continuing
benefit to investors by giving them more flexibility to closely tailor
their investment decisions and hedging decisions prior to expiration.
The Exchange also believes that the additional four days will provide
the investing public and other market participants with additional
opportunities to hedge their investment thus allowing these investors
to better manage their risk exposure with additional in the money
series. While the four additional days may generate additional quote
traffic, the Exchange does not believe that this increased traffic will
become unmanageable since the proposal remains limited to the narrow
situations when an unusual market event occurred on trading days 2, 3,
4, 5 prior to expiration.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 45 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or

(ii) as to which the self-regulatory organization consents, the
Commission will:
    (A) By order approve or disapprove the proposed rule change, or
    (B) Institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-NYSEARCA-2012-94 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEARCA-2012-94. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549, on official business days between the hours of
10:00 a.m. and 3:00 p.m. The text of the proposed rule change is
available on the Commission's Web site at http://www.sec.gov. Copies of
such filing also will be available for inspection and copying at the
principal office of the Exchange. All comments received will be posted
without change; the Commission does not edit personal identifying
information from submissions. You should submit only information that
you wish to make available publicly. All submissions should refer to
File Number SR-NYSEARCA-2012-94 and should be submitted on or before
October 11, 2012.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority. \14\
---------------------------------------------------------------------------

    \14\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2012-23237 Filed 9-19-12; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 81, Number 146 (Friday, July 29, 2016)]
[Notices]
[Pages 49993-49995]
[FR Doc No: 2016-17902]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-1039]

General Wellness: Policy for Low Risk Devices; Guidance for
Industry and Food and Drug Administration Staff; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of the guidance entitled ``General Wellness: Policy for
Low Risk Devices.'' The guidance is intended to provide clarity to
industry and FDA staff on Center for Devices and Radiological Health's
(CDRH) compliance policy for low-risk products that promote a healthy
lifestyle (general wellness products). By clarifying the policy on
general wellness products, we hope to improve the predictability,
consistency, and transparency on CDRH's regulation of these products.
For purposes of the guidance, CDRH defines ``general wellness
products'' as products which meet the following factors: They are
intended for only general wellness use as defined in the guidance and
present a low risk to the safety of users and other persons.

DATES: Submit either electronic or written comments on this guidance at
any time. General comments on Agency guidance documents are welcome at
any time.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2014-N-1039 for ``General Wellness: Policy for Low Risk Devices.''
Received comments will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at http://www.regulations.gov or at the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper

submission. You should submit two copies total. One copy will include
the information you claim to be confidential with a heading or cover
note that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.''
The Agency will review this copy, including the claimed confidential
information, in its consideration of comments. The second copy, which
will have the claimed confidential information redacted/blacked out,
will be available for public viewing and posted on http://www.regulations.gov. Submit both copies to the Division of Dockets
Management. If you do not wish your name and contact information to be
made publicly available, you can provide this information on the cover
sheet and not in the body of your comments and you must identify this
information as ``confidential.'' Any information marked as
``confidential'' will not be disclosed except in accordance with 21 CFR
10.20 and other applicable disclosure law. For more information about
FDA's posting of comments to public dockets, see 80 FR 56469, September
18, 2015, or access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
    An electronic copy of the guidance document is available for
download from the Internet. See the SUPPLEMENTARY INFORMATION section
for information on electronic access to the guidance. Submit written
requests for a single hard copy of the guidance document entitled
``General Wellness: Policy for Low Risk Devices'' to the Office of the
Center Director, Guidance and Policy Development, Center for Devices
and Radiological Health, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, Rm. 5431, Silver Spring, MD 20993-0002. Send
one self-addressed adhesive label to assist that office in processing
your request.

FOR FURTHER INFORMATION CONTACT: Bakul Patel, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5458, Silver Spring, MD 20993-0002,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    CDRH does not intend to examine low risk general wellness products
to determine whether they are devices within the meaning of section
201(h) (21 U.S.C. 321(h)) of the Federal Food, Drug, and Cosmetic Act
(FD&C Act) or, if they are devices, whether they comply with the
premarket review and postmarket regulatory requirements for devices
under the FD&C Act and implementing regulations, including, but not
limited to: Registration and listing and premarket notification
requirements (21 CFR part 807); labeling requirements (21 CFR part 801
and 21 CFR 809.10); good manufacturing practice requirements as set
forth in the Quality System regulation (21 CFR part 820); and Medical
Device Reporting (MDR) requirements (21 CFR part 803).
    For purposes of the guidance, CDRH defines ``general wellness
products'' as products which meet the following factors: (1) Are
intended for only general wellness use as defined in the guidance and
(2) present a low risk to the safety of users and other persons. A
general wellness product has an intended use that relates to
maintaining or encouraging a general state of health or a healthy
activity, or has an intended use that relates the role of healthy
lifestyle with helping to reduce the risk or impact of certain chronic
diseases or conditions and where it is well understood and accepted
that healthy lifestyle choices may play an important role in health
outcomes for the disease or condition.
    CDRH's general wellness policy applies only to general wellness
products that are low risk. In order to be considered low risk for
purposes of the guidance, the product must not: (1) Be invasive, (2) be
implanted, or (3) involve an intervention or technology that may pose
risk to the safety of users and other persons if specific regulatory
controls are not applied, such as risks from lasers or radiation
exposure.
    General wellness products may include exercise equipment, audio
recordings, video games, software programs, and other products that are
commonly, though not exclusively, available from retail establishments
(including online retailers and distributors that offer software to be
directly downloaded), when consistent with the factors outlined in the
guidance.
    The FDA published in the Federal Register of January 20, 2015 (80
FR 2712), the notice of availability for the draft guidance entitled
``General Wellness: Policy for Low Risk Devices; Draft Guidance for
Industry and Food and Drug Administration Staff'' and the comment
period for the guidance closed on April 20, 2015.

II. Significance of Guidance

    This guidance is being issued consistent with FDA's good guidance
practices regulation (21 CFR 10.115). The guidance represents the
current thinking of FDA on General Wellness: Policy for Low Risk
Devices. It does not establish any rights for any person and is not
binding on FDA or the public. You can use an alternative approach if it
satisfies the requirements of the applicable statutes and regulations.

III. Electronic Access

    Persons interested in obtaining a copy of the guidance may do so by
downloading an electronic copy from the Internet. A search capability
for all Center for Devices and Radiological Health guidance documents
is available at http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm. Guidance
documents are also available at http://www.regulations.gov. Persons
unable to download an electronic copy of ``General Wellness: Policy for
Low Risk Devices'' may send an email request to<EMAIL_ADDRESS>to receive an electronic copy of the document.
Please use the document number 1300013 to identify the guidance you are
requesting.

IV. Paperwork Reduction Act of 1995

    This guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in part 807 (registration and listing and
premarket notification (510(k))) have been approved under OMB control
numbers 0910-0625 and 0910-0120, respectively; the collections of
information in part 801 and Sec.  809.10 (labeling) have been approved
under OMB control number 0910-0485; the collections of information in
part 820 (good manufacturing practice requirements as set forth in the
quality system regulation) have been approved under OMB control number
0910-0073; and the collections of information in part 803 (MDR
requirements) have been approved under OMB control number 0910-0437.

    Dated: July 25, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-17902 Filed 7-28-16; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register: May 12, 2010 (Volume 75, Number 91)]
[Notices]
[Page 26841]
[DOCID:fr12my10-136]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

Petition for Waiver of Compliance

    In accordance with part 211 of title 49 Code of Federal Regulations
(CFR), notice is hereby given that the Federal Railroad Administration
(FRA) has received a request for a waiver of compliance from certain
requirements of its safety standards. The individual petition is
described below, including the party seeking relief, the regulatory
provisions involved, the nature of the relief being requested, and the
petitioner's arguments in favor of relief.

New Jersey Transit Corporation

[Waiver Petition Docket Number FRA-2010-0082]

    The New Jersey Transit Corporation (NJT) has petitioned FRA for an
alternate method from compliance as cited in 49 CFR 238.105, which
applies to electronic hardware and software used to control or monitor
safety functions in passenger equipment. Title 49 CFR 238.105(d)(1)
states that hardware and software that controls or monitors a train's
primary braking system shall either:
    (i) Fail safely by initiating a full service brake application in
the event of a hardware or software failure that could impair the
ability of the engineer to apply or release the brakes or;
    (ii) Access to direct manual control of the primary braking system
(both service and emergency braking) shall be provided to the engineer.
    NJT recently placed an order for 27 ALP-46A electric passenger
locomotives, and the braking software being provided by the
manufacturer only partly meets the above requirements.
    The railroad explains in their petition that the full service brake
application is transmitted electronically to each MU's Friction Brake
Control Unit (FBCU). FBCU then provides the requested brake application
without drawing down brake pipe pressure. An Emergency Magnetic Valve
(EMV) is provided on each MU for an electric emergency brake
application. During normal operations, EMVs are energized in the closed
position and any loss of power or software malfunction causes EMVs to
open and vent to atmosphere causing the brakes over the entire consist
to apply at an emergency rate.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested party
desires an opportunity for oral comment, they should notify FRA, in
writing, before the end of the comment period and specify the basis for
their request.
    All communications concerning these proceedings should identify the
appropriate docket number (e.g., Waiver Petition Docket Number FRA-
2010-0082) and may be submitted by any of the following methods:
     Web site: http://www.regulations.gov. Follow the online
instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: Docket Operations Facility, U.S. Department of
Transportation, 1200 New Jersey Avenue, SE., W12-140, Washington, DC
20590.
     Hand Delivery: 1200 New Jersey Avenue, SE., Room W12-140,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
    Communications received within 45 days of the date of this notice
will be considered by FRA before final action is taken. Comments
received after that date will be considered as far as practicable. All
written communications concerning these proceedings are available for
examination during regular business hours (9 a.m.-5 p.m.) at the above
facility. All documents in the public docket are also available for
inspection and copying on the Internet at the docket facility's Web
site at http://www.regulations.gov.
    Anyone is able to search the electronic form of any written
communications and comments received into any of our dockets by the
name of the individual submitting the document (or signing the
document, if submitted on behalf of an association, business, labor
union, etc.). You may review DOT's complete Privacy Act Statement in
the Federal Register published on April 11, 2000 (65 FR 19477) or at
http://www.dot.gov/privacy.html.

    Issued in Washington, DC on May 6, 2010.
Grady C. Cothen, Jr.,
Deputy Associate Administrator for Safety Standards and Program
Development.
[FR Doc. 2010-11208 Filed 5-11-10; 8:45 am]
BILLING CODE 4910-06-P